| Name | Title | Contact Details |
|---|
T3D Therapeutics` mission is to develop its lead drug product candidate, T3D-959, as a potential `First-in-Class`and `Best-in-Class` disease-modifying, breakthrough medicine for the treatment of Alzheimer`s disease with the potential to slow, stop or reverse the course of the disease. The Company is also seeking to maximize the therapeutic utility of T3D=959 and has initiated pre-clinical studies in Huntington’s Disease models.
Fister Lauberth is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MedCases Inc is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Timber PT Management is a company that offers revenue cycle management services to private physical therapy groups seeking to expand their practices.
Charles T Sitrin Health Care is a New Hartford, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.